Jounce Therapeutics
JNCE
Delayed Nasdaq - 06/22 10:00:00 pm
8.51USD
+4.42%
Upcoming events on JOUNCE THERAPEUTICS INC
08/08/18 Interim 2018 Earnings Release (Projected)
11/12/18 Q3 2018 Earnings Release (Projected)
03/07/19 FY 2018 Earnings Release (Projected)
Past events on JOUNCE THERAPEUTICS INC
06/19/18 | 07:00pmAnnual General Meeting
06/05/18American Society of Clinical Oncology Meeting
06/02/18 | 10:00pmAmerican society of clinical oncology meeting - abstract number: 000
05/09/18Q1 2018 Earnings Release
Upcoming sector events for JOUNCE THERAPEUTICS INC
06/26/18 | 08:00pm NEKTAR THERAPEUTICS : Annual General Meeting
06/26/18 | 03:30pm UNITED THERAPEUTICS CORPORATION : Annual General Meeting
07/24/18 EXACT SCIENCES CORPORATION : Interim 2018 Earnings Release (Projected)
07/24/18 | 04:00pm ICON PLC : Annual General Meeting
Past sector events for JOUNCE THERAPEUTICS INC
06/21/18 | 07:00pmINCYTE CORPORATION : Investor Day
06/21/18 | 03:00pmFOUNDATION MEDICINE INC : Annual General Meeting
06/21/18QIAGEN NV : J.P. Morgan European Health Care Conference
06/21/18GENMAB A/S : J.P. Morgan European Health Care Conference
Annual results
Annual results20172018 (e)
Sales
Million $
Released
Forecast
Spread
71,6
75,5
-5,2%

52,6
Operating income (EBITDA)
Million $
Released
Forecast
Spread
-14,8
-15,0
1,4%

-50,9
Operating profit (EBIT)
Million $
Released
Forecast
Spread
-19,2
-26,3
27%

-55,2
Pre-Tax Profit (EBT)
Million $
Released
Forecast
Spread
-16,4
-24,0
32%

-52,5
Net income
Million $
Released
Forecast
Spread
-17,2
-26,7
35%

-52,5
EPS
 $
Released
Forecast
Spread
-0,57
-0,65
12%

-1,54
Announcement Date03/08/2018
Quarterly / Semiannualy publications
Quarterly resultsQ1
2018
Q2
2018 (e)
Sales
Million $
Released
Forecast
Spread
11,2
15,1
-26%

13,3
Operating income (EBITDA)
Million $
Released
Forecast
Spread
-12,8
-11,5
-12%

-12,8
Operating profit (EBIT)
Million $
Released
Forecast
Spread
-13,8
-10,6
-30%

-13,2
Pre-Tax Profit (EBT)
Million $
Released
Forecast
Spread
-13,0
-10,2
-27%

-13,1
Net income
Million $
Released
Forecast
Spread
-13,0
-10,5
-24%

-12,5
EPS
 $
Released
Forecast
Spread
-0,40
-0,32
-24%

-0,34
Announcement Date05/09/2018